moxifloxacin has been researched along with Dry Eye Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielory, L; Kumar, S; Syed, BA | 1 |
| Gregory, DG | 1 |
1 review(s) available for moxifloxacin and Dry Eye Syndromes
| Article | Year |
|---|---|
Current options and emerging therapies for anterior ocular inflammatory disease.
Topics: Anti-Infective Agents; Antibodies, Monoclonal; Chemokine CCL11; Clinical Trials as Topic; Conjunctivitis, Allergic; Cyclosporine; Dibenzoxepins; Dry Eye Syndromes; Fluoroquinolones; Histamine H1 Antagonists; Humans; Immunotherapy; Levofloxacin; Moxifloxacin; Olopatadine Hydrochloride; Uveitis, Anterior | 2014 |
1 other study(ies) available for moxifloxacin and Dry Eye Syndromes
| Article | Year |
|---|---|
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
Topics: Acute Disease; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cyclosporine; Dexamethasone; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorophotometry; Fluoroquinolones; Glucocorticoids; Guidelines as Topic; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Tobramycin; Visual Acuity | 2016 |